CONFIDENTIAL TREATMENT REQUESTED EXHIBIT 10.78 CONFIDENTIAL TREATMENT REQUESTED UNDER RULE 24(b)(2) OF THE SECURITIES AND EXCHANGE ACT OF 1934. CONFIDENTIAL TREATMENT REQUESTED IS REQUESTED AND IS NOTED WITH "[CONFIDENTIAL TREATMENT REQUESTED]." AN...Exclusivity Agreement • May 16th, 2005 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances
Contract Type FiledMay 16th, 2005 Company Industry
AMENDMENT TO SUPPLEMENTAL AGREEMENT EXHIBIT 10.79 This Amendment to the Supplemental Agreement (this "Amendment"), dated as of February 7, 2005 (the "Amendment Date"), is made and entered into by and among Nektar Therapeutics ("Nektar", formerly known...Supplemental Agreement • May 16th, 2005 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • California
Contract Type FiledMay 16th, 2005 Company Industry Jurisdiction